Keystone Financial Planning Inc. bought a new position in shares of Cigna Group (NYSE:CI - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 13,510 shares of the health services provider's stock, valued at approximately $3,672,000. Cigna Group makes up about 0.7% of Keystone Financial Planning Inc.'s investment portfolio, making the stock its 21st biggest position.
Other hedge funds also recently modified their holdings of the company. BlackRock Inc. lifted its position in Cigna Group by 3.7% during the second quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider's stock worth $6,461,457,000 after purchasing an additional 840,098 shares during the period. GQG Partners LLC bought a new position in Cigna Group in the 2nd quarter valued at about $1,628,918,000. Bank of America Corp DE lifted its holdings in shares of Cigna Group by 8.8% during the 1st quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider's stock worth $848,821,000 after acquiring an additional 256,677 shares during the period. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Cigna Group by 9.8% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,958,656 shares of the health services provider's stock worth $814,311,000 after acquiring an additional 263,036 shares during the period. Finally, Dimensional Fund Advisors LP boosted its position in shares of Cigna Group by 10.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,426,218 shares of the health services provider's stock worth $647,008,000 after acquiring an additional 236,340 shares in the last quarter. Institutional investors own 86.99% of the company's stock.
Cigna Group Trading Up 0.9%
Shares of CI stock opened at $281.10 on Friday. The firm has a market capitalization of $74.28 billion, a P/E ratio of 11.63, a P/E/G ratio of 0.94 and a beta of 0.29. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock's fifty day simple moving average is $277.35 and its 200 day simple moving average is $280.94. Cigna Group has a twelve month low of $239.51 and a twelve month high of $312.18.
Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business had revenue of $71.56 billion during the quarter, compared to analyst estimates of $70.14 billion. During the same quarter last year, the business earned $7.20 EPS. The firm's quarterly revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, sell-side analysts predict that Cigna Group will post 30.5 EPS for the current fiscal year.
Cigna Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th were issued a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date was Tuesday, September 8th. Cigna Group's dividend payout ratio is presently 25.82%.
Insider Activity
In other Cigna Group news, insider Nicole Jones sold 19,436 shares of Cigna Group stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the transaction, the insider directly owned 27,256 shares of the company's stock, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the company's stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the sale, the insider owned 5,053 shares in the company, valued at $1,435,304.65. This trade represents a 10.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 22,730 shares of company stock worth $6,293,359 over the last ninety days. Company insiders own 0.60% of the company's stock.
Analyst Ratings Changes
CI has been the topic of a number of recent analyst reports. UBS Group reissued a "buy" rating on shares of Cigna Group in a research note on Thursday, October 1st. Raymond James Financial downgraded Cigna Group from a "strong-buy" rating to an "outperform" rating and reduced their target price for the company from $350.00 to $320.00 in a report on Monday, August 3rd. Royal Bank Of Canada reiterated an "outperform" rating and issued a $337.00 price target on shares of Cigna Group in a research note on Thursday, October 1st. Wells Fargo & Company boosted their price target on Cigna Group from $305.00 to $307.00 and gave the stock an "equal weight" rating in a report on Friday, July 31st. Finally, Evercore started coverage on Cigna Group in a research report on Wednesday, September 9th. They set an "in-line" rating and a $290.00 price objective for the company. Fifteen analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, Cigna Group currently has a consensus rating of "Moderate Buy" and an average price target of $338.24.
View Our Latest Research Report on Cigna Group
Cigna Group Company Profile
(
Free Report)
The Cigna Group NYSE: CI is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.
Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.
Featured Articles
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.